J-Pharma Co (TSE:520A) EV-to-FCF: (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, J-Pharma Co's Enterprise Value is 円2,840.86 Mil. J-Pharma Co does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate J-Pharma Co's EV-to-FCF at this moment.

The historical rank and industry rank for J-Pharma Co's EV-to-FCF or its related term are showing as below:

TSE:520A' s EV-to-FCF Range Over the Past 10 Years
Min: -1.75   Med: 0   Max: 0
Current: -1.75
TSE:520A's EV-to-FCF is ranked worse than
100% of 335 companies
in the Biotechnology industry
Industry Median: 15.34 vs TSE:520A: -1.75

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-14), J-Pharma Co's stock price is 円290.00. J-Pharma Co does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate J-Pharma Co's PE Ratio (TTM) at this moment.

J-Pharma Co  (TSE:520A) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

J-Pharma Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=290.00/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

J-Pharma Co EV-to-FCF Related Terms

J-Pharma Co EV-to-FCF Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co EV-to-FCF Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
EV-to-FCF
0.00 0.00

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
EV-to-FCF 0.00 0.00 0.00

TSE:520A vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, J-Pharma Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J-Pharma Co EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, J-Pharma Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where J-Pharma Co's EV-to-FCF falls into.


TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co EV-to-FCF Calculation

J-Pharma Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2840.858/
=

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price